Pharmaceutical composition containing aminoacetonitril compounds and the use thereof for the prepartion of a pharmaceutical composition for the treatment of endoparasitic pests in animals

Details for Australian Patent Application No. 2002250841 (hide)

Owner Novartis AG

Inventors Ducray, Pierre; Bouvier, Jacques

Agent Davies Collison Cave

Pub. Number AU-B-2002250841

PCT Pub. Number WO2002/060257

Priority 0097/01 22.01.01 CH

Filing date 21 January 2002

Wipo publication date 12 August 2002

Acceptance publication date 3 March 2005

International Classifications

A01N 037/34 Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - Nitriles

A61K 031/277

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002250841

3 March 2005 Application Accepted

  Published as AU-B-2002250841

30 June 2005 Standard Patent Sealed

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002250842-DNA sequence of the enzyme phospholipase A1 of ciliate tetrahymena, and the use of the same

2002250840-Chromane derivatives, process for their preparation and their use as antitumor agents